Latest Trending
Last Updated, Feb 23, 2023, 10:30 AM
Wall Street Backs New Class of Psychedelic Drugs

[ad_1]

Wall Street is betting tens of millions of dollars on psychedelic drugs that backers say could treat mental illness for a fraction of what it costs to do therapy with better-known treatments.

Transcend Therapeutics Inc. raised $40 million from venture-capital investors in January to develop a post-traumatic stress disorder treatment that its 29-year-old CEO Blake Mandell says would require about half the amount of therapy as MDMA, or ecstasy, a popular hallucinogen. Gilgamesh Pharmaceuticals Inc. and Lusaris Therapeutics Inc. have announced capital raises of about $100 million since November for similar products addressing depression. 

What’s News

[ad_2]

Source link

24World Media does not take any responsibility of the information you see on this page. The content this page contains is from independent third-party content provider. If you have any concerns regarding the content, please free to write us here: contact@24worldmedia.com

Latest Post

Zosia VanMeter becomes Director of Inspection

Last Updated,Nov 27, 2024

Saugus playground gets revamped – Itemlive

Last Updated,Nov 27, 2024

Fatal Mattituck fire raises questions about rental safety

Last Updated,Nov 27, 2024

Photos: CAST’s 5th Annual Festival of Trees lights up Treiber Farms in Peconic

Last Updated,Nov 27, 2024

Daily Update: Fatal Mattituck fire raises questions about rental safety

Last Updated,Nov 27, 2024

Lynn football luncheon scores big

Last Updated,Nov 27, 2024

Police Logs 11/27/24 – Itemlive

Last Updated,Nov 27, 2024

Marblehead strike settled – Itemlive

Last Updated,Nov 27, 2024

Four Classical greats honored in City Hall

Last Updated,Nov 27, 2024

Swampscott hosts Thanksgiving Hero Meals

Last Updated,Nov 27, 2024

Controversial project redesign OK’d in Peabody

Last Updated,Nov 27, 2024

LYSOA celebrates its relaunch with a new logo and expanded program

Last Updated,Nov 27, 2024